2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Revenue | $3.8B | $6B | $7.3B | $6.9B | $9.9B |
Cost of Revenue | $0 | $0 | $0 | $0 | $0 |
Gross Profit | $3.8B | $6B | $7.3B | $6.9B | $9.9B |
Gross Profit % | 100% | 100% | 100% | 100% | 100% |
R&D Expenses | $0 | $0 | $0 | $0 | $0 |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Net Income | $817M | $1.3B | $2.2B | $2B | $2B |
Dep. & Amort. | $367M | $391M | $484M | $798M | $622M |
Def. Tax | -$93M | -$76M | $319M | -$302M | -$26M |
Stock Comp. | $77M | $129M | $105M | $97M | $106M |
Chg. in WC | -$891M | $353M | $570M | -$339M | -$1.3B |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Cash | $6.7B | $5.9B | $6.7B | $10B | $1.7B |
ST Investments | $16B | $28B | $511M | $0 | $27B |
Cash & ST Inv. | $23B | $34B | $6.7B | $10B | $29B |
Receivables | $0 | $5B | $0 | $0 | $7.6B |
Inventory | $0 | $0 | $0 | $0 | $0 |
HBAN delivered exceptional Q1 results, with robust loan growth (average loans up nearly $9B YoY, 2.1% QoQ) and continued deposit growth (average deposits up almost $11B YoY, 1.4% QoQ), outperforming peers and ahead of internal plans for the year.
The company increased its full-year 2025 guidance for net interest income to +5% to 7% (reflecting record levels), expects loan growth within 5%-7%, deposit growth within 3%-5%, fee revenue growth of 4%-6%, and expense growth of 3.5%-4.5%; Q2 is expected to see continued strong loan and deposit growth, modest NII and fee revenue increases, and expenses around $1.07B.
Net interest margin (NIM) outperformed expectations, coming in at 3.07% for Q1, with management expecting a flat NIM around this level for the remainder of 2025 under most rate scenarios; strong deposit pricing execution was a key driver.
Credit quality remains strong: net charge-offs were 26 bps, allowance for credit losses at 1.87%, and the company maintains a top-tier reserve position; management continues to model multiple economic scenarios and remains cautious but optimistic.
HBAN’s Board approved a $1B multi-year share repurchase authorization, providing flexibility for capital deployment; any buybacks in 2025 are expected to be modest, with capital priorities remaining focused on growth, dividends, and then repurchases.